Pharmacological agents currently in clinical trials for disorders in neurogastroenterology

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

Esophageal, gastrointestinal, and colonic diseases resulting from disorders of the motor and sensory functions represent almost half the patients presenting to gastroenterologists. There have been significant advances in understanding the mechanisms of these disorders, through basic and translational research, and in targeting the receptors or mediators involved, through clinical trials involving biomarkers and patient responses. These advances have led to relief of patients' symptoms and improved quality of life, although there are still significant unmet needs. This article reviews the pipeline of medications in development for esophageal sensorimotor disorders, gastroparesis, chronic diarrhea, chronic constipation (including opioid-induced constipation), and visceral pain.

Original languageEnglish (US)
Pages (from-to)4111-4120
Number of pages10
JournalJournal of Clinical Investigation
Volume123
Issue number10
DOIs
StatePublished - Oct 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this